Blueprint Genetics
Latest round
- Series A
Last raised
- Jul 2017
Total raised
- $20M
Investors
- 7
About Blueprint Genetics
Blueprint Genetics Oy, founded in 2012 and headquartered in Espoo, Finland, focuses on providing advanced genetic testing solutions. In January 2020, Quest Diagnostics acquired Blueprint Genetics, enhancing its operations in the genetic testing market.Blueprint Genetics specializes in advanced genetic testing and diagnostics, offering a comprehensive portfolio that includes Whole Exome Sequencing, variant-specific testing, and customizable diagnostic panels across 14 medical specialties. Their services cater to healthcare providers and research institutions, enhancing patient outcomes through accurate genetic diagnoses.70.Following the acquisition by Quest Diagnostics in January 2020, Blueprint Genetics aims to expand its product offerings and enter new markets. The company plans to introduce new testing products in the coming years and expand its presence in North America and Europe.
Who invested in Blueprint Genetics
7 investors across 2 rounds
See all investors in Blueprint Genetics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Blueprint Genetics
Who invested in Blueprint Genetics?
Blueprint Genetics has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Blueprint Genetics raised?
Blueprint Genetics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Blueprint Genetics last raise money?
Blueprint Genetics's most recent round on record is a Series A, in Jul 2017.
What does Blueprint Genetics do?
Blueprint Genetics Oy, founded in 2012 and headquartered in Espoo, Finland, focuses on providing advanced genetic testing solutions.
Where is Blueprint Genetics headquartered?
Blueprint Genetics is headquartered in Espoo, Finland.
Which VCs invest in companies like Blueprint Genetics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Blueprint Genetics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Blueprint Genetics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.